PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Anaesthesiology and Reanimation, Sakarya University Education and Research Hospital, Sakarya, Turkey.\', \'Department of Intensive Care, Sakarya University Education and Research Hospital, Sakarya, Turkey.\', \'Department of Internal Medicine, Sakarya University Education and Research Hospital, Sakarya, Turkey.\', \'Department of Nephrology, Sakarya University Education and Research Hospital, Sakarya, Turkey.\', \'Department of Infectious Diseases and Clinical Microbiology, Sakarya University Education and Research Hospital, Sakarya, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jcpt.13305
?:hasPublicationType
?:journal
  • Journal of clinical pharmacy and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33128482
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.722
?:rankingScore_hIndex
  • 61
?:title
  • Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all